(Press-News.org) AUG. 29, 2013, Cleveland:
The mutation occurs in the androgen-synthesizing enzyme 3βHSD1 in castration-resistant prostate cancer (CRPC), according to research published online today in Cell. This mutation enables the tumor to make its own supply of androgens, a hormone that fuels the growth of the prostate cancer.
Prostate cancer requires a constant supply of androgens in order to sustain itself. The current standard of care for patients with metastatic prostate cancer is medical castration, the ability to interfere with the body's production of testosterone (androgens) using medications that disrupt the process. Oftentimes, metastatic prostate cancer flourishes despite the lack of testosterone in the bloodstream, creating CRPC. These tumors are able to exist without the body's supply of testosterone by creating androgens within the tumor cell; however, increased androgen synthesis has not yet been attributable to any known mutations. The Cleveland Clinic discovery shows that the 3βHSD1 mutation makes this enzyme hyperactive to create androgens.
"This discovery gives us the ability to identify molecular subtypes of prostate cancer known to resist treatment. By finding the mutated enzyme, we can now investigate treatments that block it. This kind of strategy is the crux of personalized medicine which is currently used as the standard of care for some forms of lung cancer and melanoma," said Nima Sharifi, M.D., Kendrick Family Chair for Prostate Cancer Research at Cleveland Clinic, who led the research.
The 3βHSD1 mutation can occur within CRPC tumors and it can also come from germline DNA, which is inherited from maternal and paternal sources.
The research found that laboratory models of human prostate cancer fall into two categories of androgen synthesis: those that make androgens slowly and those that do so rapidly. Next, they found that the 3βHSD1 mutation explains the difference between these two categories and that DNA from some patient tumors also contains this mutation. The mutation works by opening the floodgates to androgen synthesis, essentially throwing fuel on the fire that promotes tumor progression.
In an era of personalized cancer care, there is increased focus on defining and treating cancer by its genetic abnormalities. Tumor-promoting enzyme mutations in several cancers have been identified and, subsequently, have led to the development of targeted drug therapies, improving outcomes for patients.
"The past decade has seen an explosion of molecularly targeted therapies that are matched to specific mutations in a given patient's tumor," says Dr. Sharifi. "However, no drug-targeting based on enzyme mutations exists for the standard treatment of metastatic CRPC. With this finding, we have the opportunity for matching a mutant disease-driving biomarker with a pharmacologic inhibitor."
Prostate cancer is the most common cancer in men, with nearly 240,000 new cases diagnosed each year in the United States. According to the American Cancer Society, there will be an estimated 30,000 deaths due to prostate cancer in 2013. Almost every man who dies of prostate cancer dies with castration-resistant prostate cancer.
###
This research was funded by Prostate Cancer Foundation, American Cancer Society, Department of Defense, Howard Hughes Medical Institute and National Cancer Institute.
For more information on Cleveland Clinic's cancer services, visit clevelandclinic.org/cancer.
About Cleveland Clinic
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S.News & World Report consistently names Cleveland Clinic as one of the nation's best hospitals in its annual "America's Best Hospitals" survey. More than 3,000 full-time salaried physicians and researchers and 11,000 nurses represent 120 medical specialties and subspecialties. The Cleveland Clinic health system includes a main campus near downtown Cleveland, more than 75 Northern Ohio outpatient locations, including 16 full-service Family Health Centers, Cleveland Clinic Florida, the Lou Ruvo Center for Brain Health in Las Vegas, Cleveland Clinic Canada, and, currently under construction, Cleveland Clinic Abu Dhabi. In 2012, there were 5.1 million outpatient visits throughout the Cleveland Clinic health system and 157,000 hospital admissions. Patients came for treatment from every state and from more than 130 countries. Visit us at http://www.clevelandclinic.org. Follow us at http://www.twitter.com/ClevelandClinic.
Contacts:
Stephanie Jansky
216.636.5869
janskys@ccf.org
Tora Vinci
216.444.2412
vinciv@ccf.org
Cleveland Clinic researcher finds genetic mutation in castration-resistant prostate cancer
Discovery could lead to development of biomarkers and new targeted therapies
2013-08-29
ELSE PRESS RELEASES FROM THIS DATE:
Rim Fire update Aug. 29, 2013
2013-08-29
Slowly but surely, the Rim Fire in California is being contained. Currently it is 30% contained. The fire has burned over 192,000 acres. The use of aircraft and water/chemical dumping on the fire has been instrumental in slowing/stopping blazes.
The update as of Aug. 29 from Inciweb.org is as follows: "Firefighters used aerial ignitions today to burnout Pilot Ridge on the southern portion of the fire. The burnout planned from Hetch Hetchy Reservoir south to Tioga Road in Yosemite National Park did not occur. Conditions were not conducive to lighting and containing ...
Fires plague Portugal
2013-08-29
Portugal has been experiencing the worst drought in years. Drought and the dry conditions that follow lead to wildfires set by just a spark or a lightning strike. Portugal's north has been plagued with wildfires due to these such conditions. Spain and France have joined their firefight lending water-dumping aircraft in an effort to quell the raging fires. The dry conditions, heat, high winds, and difficult terrain in the area where the fires have been most active have produced what the firefighters over there have dubbed "the perfect storm."
Portugal's Serra da Estrela ...
Adding blood pressure drug to standard antibiotics speeds up TB treatment
2013-08-29
Infectious disease experts at Johns Hopkins have found, in studies in mice, that a drug better known as a treatment for high blood pressure and headaches effectively speeds up treatment of TB when added to the standard, daily antibiotic regimen. Test animals were cured in four months instead of the usual six.
Researchers say that if clinical trials starting later this year in India, a country heavily burdened by the highly contagious lung disease, prove successful, then the shortened treatment time with verapamil, a so-called calcium channel blocker, used in combination ...
New imaging technology promising for several types of cancer
2013-08-29
CLEVELAND: Researchers from University Hospitals Case Medical Center have published findings that a new form of imaging -- PET/MRI -- is promising for several types of cancer. In an article titled "PET/MRI: Applications in Clinical Imaging," published in the September issue of Current Radiology Reports, the authors outline their initial clinical experience in diagnosing and staging cancer patients with this novel technology.
Working in collaboration with researchers from Philips Healthcare, the team found that PET/MRI provided added value in the diagnosis, staging and ...
Newly discovered weakness in cancer cells make them more susceptible to chemotherapy
2013-08-29
Bethesda, MD—A new weakness has been discovered in cancer cells that may make them more susceptible to chemotherapy and other treatments. In a research report appearing in the September 2013 issue of The FASEB Journal, scientists identify the HDAC5 protein as being essential for the maintenance of structures, called telomeres, within cancer cells that promote cancer cells longevity. Cancer cells with longer telomeres tend to be more resistant to therapies, while cancer cells with shorter telomeres tend to be more susceptible. By targeting the mechanism used by cancer cells ...
Discovering a diamondback moth: Overlooked diversity in a global pest
2013-08-29
The tiny diamondback moth (scientific name: Plutella xylostella) gets its common name from the array of diamond shapes along the margin of its forewing. Despite their diminutive size, the caterpillars of the diamondback moth exert tremendous damage on many crops including cabbage, broccoli, and crucifers at large. More than $1 billion is spent globally each year in efforts to control damage by this moth, reflecting its amazing capacity to evolve resistance to both insecticides and biological control agents.
A global study of DNA barcodes by two Canadian entomologists ...
Dieting for obese mothers just before pregnancy may not be enough
2013-08-29
Bethesda, MD—While there is never a bad time to address one's own obesity, if you're hoping to lose weight before conception for the sake of your child, here's some bad news: Some of the epigenetic damage might have already been done, even if you lose the weight just before conception. According to new research published in the September 2013 issue of The FASEB Journal, not only is dieting before getting pregnant not enough to prevent diabetes risks, but it could actually present new risks as well. Knowing how maternal health and behavior affect how genes express themselves ...
Reproducing nature's chemistry: Researchers alter molecular properties in a new way
2013-08-29
In their search for molecules with certain characteristics, chemists have produced millions of new, increasingly complex synthetic materials by altering molecules' chemical structures.
Taking cues from nature, Northwestern University researchers have recently tested a new method for achieving the molecular properties they seek: by changing the geometry of the surface to which molecules are bound.
"For years chemists have been making molecules to solve problems — each one more synthetically complicated than the last — but we still haven't come close to achieving what ...
Scripps Florida scientists detail critical role of gene in many lung cancer cases
2013-08-29
JUPITER, FL, August 29, 2013 – Scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown that a well-known cancer-causing gene implicated in a number of malignancies plays a far more critical role in non-small cell lung cancer, the most common form of the disease, than previously thought.
These findings establish the gene as a critical regulator of lung cancer tumor growth. This new information could turn out to be vital for the design of potentially new therapeutic strategies for a group of patients who represent almost half of non-small ...
Doubling the daily allowance of protein intake with diet and exercise protects muscle loss
2013-08-29
Bethesda, MD—A new report appearing in the September issue of The FASEB Journal challenges the long-held adage that significant muscle loss is unavoidable when losing weight through exercise and diet. In the report, scientists show that consuming twice the recommended daily allowance (RDA) of protein while adhering to a diet and exercise plan prevents the loss of muscle mass and promotes fat loss. Tripling the RDA of protein, however, failed to provide additional benefits.
"It is our hope that the findings from this well-controlled study will be discussed and cited by ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] Cleveland Clinic researcher finds genetic mutation in castration-resistant prostate cancerDiscovery could lead to development of biomarkers and new targeted therapies